Regarding your site on solid state magnetic field, I could not see were the double blind studies were done by the medical field and you know as well as I do that we are not talking about the same thing, I could not see the FDA registration as a medical device on your S.S. bio-magnetism? all that was there was a lot of advertising for your product, further more you have no clue how the Bemer works since nothing pertained to the actual procedure of the product, all you were referring to was the delivery system! that can be done on the new Bemer though light without the electromagnetic procedure or the electromagnetic system which are only the delivery system!
G.
Below is a a picture
Bemer - Premature Baby | Facebook
it prevents the premature lungs from collapse
Below is the double-blind
Effect of BEMER magnetic field therapy on the level of fatigue in patients with multiple sclerosis: a randomized, double-blind controlled trial.
http://www.ncbi.nlm.nih.gov/pubmed/19422286Abstract
OBJECTIVES:
Electromagnetic field therapy has been reported to be beneficial in patients with multiple sclerosis (MS) with significant fatigue. This study was designed to evaluate the long-term effects of Bio-Electro-Magnetic-Energy-Regulation (BEMER) on MS-related fatigue.
DESIGN:
This was a monocenter, patient- and rater-blinded, placebo-controlled trial.
PATIENTS:
There were 37 relapsing-remitting patients with MS with significant fatigue in the study.
INTERVENTION:
The intervention consisted of BEMER magnetic field treatment for 8 minutes twice daily in comparison to placebo for 12 weeks.
OUTCOME MEASURES:
The primary outcome criterion was change in the Modified Fatigue Impact Scale (MFIS) between baseline and 12 weeks. The secondary outcome criteria were changes of the Fatigue Severity Scale (FSS), a general depression scale-long version (ADS-L), Multiple Sclerosis Functional Scale (MSFC), and the Expanded Disability Status Scale (EDSS).
RESULTS:
There was evidence of a significant difference of MFIS value (primary outcome criterion) after 12 weeks in favor of the verum group (26.84 versus 36.67; p = 0.024). In addition, FSS values were significantly lower in the verum group after 12 weeks (3.5 versus 4.7; p = 0.016). After 6 weeks' follow-up, verum and placebo groups did not differ in experienced fatigue (MFIS, FSS). Regarding the subscales of the MFIS, there was a significant decrease in physical (p = 0.018) and cognitive (p = 0.041), but not in psychologic subscales only in the verum group regarding the timepoints baseline and 12 weeks. BEMER therapy was well tolerated.
DISCUSSION:
In this pilot study, we were able to demonstrate a beneficial effect of BEMER intervention on MS fatigue. As this was only a pilot study, trials with more patients and longer duration are mandatory to describe long-term effects.
«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»§«¤»¥«¤»«¤»§«¤»¥«¤»§«¤»¥«¤»
§ Health_and_Healing - PULSE ON 21st CENTURY ALTERNATIVE MEDICINE & WORLD NEWS
http://groups.yahoo.com/group/Health_and_Healing
Subscribe send email to:
http://Health_and_Healing-subscribe@yahoogroups.com
Alternative Health and Old Time Cures:
http://ElementsOfHealth.webs.com
Sacred Geometry Health Pendants / LIVING CALCIUM GREEN BENTONITE CLAY, SO PURE IT IS FOOD GRADE FOR INTERNAL OR EXTERNAL USE. http://www.HolisticEnergyStore.com/
THE OPEN LINE NEWSPAPER, HEALTH NEWS, SPIRITUAL, ENVIRONMENT, ETC. http://WWW.THEOPENLINE.ORG
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.